Incidence of neuroendocrine cells in the seminal vesicles and the prostate - An immunohistochemical study

International Urology and Nephrology

Volumn 34, Issue 3, 2002, Pages 357-360

  Sommerfeld, Hans Jörg ^a   Partin, Alan Wayne ^b   Pannek, Jürgen ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Carcinogenesis; Chromogranin A; Neuroendocrine; Prostate; Seminal vesicles

Indexed keywords

BIOGENIC AMINE; CHROMOGRANIN A; GROWTH FACTOR; PEPTIDE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; GROWTH REGULATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NEUROSECRETORY CELL; PROSTATE; PROSTATE CANCER; SEMINAL VESICLE; STEM CELL;

APUD CELLS; CHROMOGRANIN A; CHROMOGRANINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; SEMINAL VESICLES; TUMOR MARKERS, BIOLOGICAL;

EID: 0041312654     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024467000088     Document Type: Article

References (24)

1. Abrahamsson PA, Wadstrøm LB, Alumets J et al. Peptide-hormone and serotonin-immunoreactive tumour cells in carcinoma of the prostate. Pathol Res Pract 1987; 182: 298-307.
2. Di Sant'Agnese PA. Neuroendocrine differentiation in the precursors of prostate cancer. Eur Urol 1996; 30: 185-190.
3. Di Sant'Agnese PA, De Mesy-Jensen KL. Neuroendocrine differentiation in prostatic carcinoma. Hum Pathol 1987; 8: 849-856.
4. Di Sant'Agnese PA. Neuroendocrine differentiation in carcinoma of the prostate. Cancer 1992; 70: 254-268.
5. Abrahamsson PA, Falkner S, Falt K et al. The course of neuroendocrine differentiation in prostatic carcinomas. Pathol Res Pract 1989; 185: 373-380.
6. Aprikian AG, Cordon-Cardo C, Fair WR et al. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer 1993; 71: 3952-3965.
7. Cohen MK, Arber DA, Coffield KS et al. Neuroendocrine differentiation in prostatic adenocarcinoma and its relationship to tumor progression. Cancer 1994; 74: 1899-1903.
8. Nakada SY, Di Sant'Agnese PA, Moynes RA et al. The androgen receptor status of neuroendocrine cells in human benign and malignant prostatic tissue. Cancer Res 1993; 53: 1967-1970.
9. Di Sant'Agnese PA, De Mesy-Jensen K. Endocrine-paracrine cells of the prostate and prostatic urethra: An ultrastructural study. Hum Pathol 1984; 15: 1034-1041.
10. Angelsen A, Syversen U, Haugen OV et al. Neuroendocrine differentiation in carcinomas of the prostate: Do neuroendocrine markers reflect immunohistochemical findings? Prostate 1997; 30: 1-6.
11. Pearse A. The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic, and pathologic implications of the concepts. J Histochem Cytochem 1969; 17: 303-313.
12. Abrahamsson PA, Lilja H. Partial characterization of a thyroid-stimulating hormone-alike peptide in neuroendocrine cells of the human prostate gland. Prostate 1989; 14: 71-81.
13. Fetissof F, Bertrand G, Guilloteau D et al. Calcitonin immunoreactive cells in prostate gland and cloacal derived tissues. Virchows Arch (A) 1986; 409: 523-533.
14. Gkonos PJ, Krongrad A, Roos BA. Neuroendocrine peptides in the prostate. Urol Res 1995; 23: 81-87.
15. Noordzij MA, Van Der Kwast TH, Van Steenbrugge GJ et al. The prognostic influence of neuroendocrine cells in prostate cancer: Results of a long-term follow-up study with patients treated by radical prostatectomy. Int J Cancer 1995; 62: 252-258.
16. Bostwick DG, Dousa MK, Crawford BG et al. Neurocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma. Am J Surg Pathol 1994; 18: 1240-1246.
17. Cohen RJ, Glezerson G, Taylor LF et al. The neuroendocrine cell population of the human prostate gland. J Urol 1993; 150: 365-368.
18. Di Sant'Agnese PA, De Mesy-Jensen KL, Churucian CV et al. Human prostatic endocrine-paracrine (APUD) cells: Distributional analysis with a comparison of serotonin and neuron-specific enolase immunoreactivity and silver stains. Arch Pathol Lab Med 1985; 109: 607-612.
19. Epstein JI, Partin AW, Veltri R. Neuroendocrine differentiation (NE) in prostate cancer: Enhanced prediction of progression following radical prostatectomy. Lab Invest 1995; 72: 75A.
20. Iwamura M, Gershagen S, Lapets O et al. Immunohistochemical localization of parathyroid hormone-related protein in prostatic intraepithelial neoplasia. Hum Pathol 1995; 26: 797-801.
21. Pannek J, Lecksell KL, Partin AW. Expression of metallothionein in seminal vesicles. Scand J Urol Nephrol 2001; 35: 11-14.
22. Pannek J, Berges RR, Sauvageot J et al. Cell turnover in human seminal vesicles and the prostate: An immunohistochemical study. Prostate Cancer and Prost Dis 1999; 2: 200-203.
23. Pannek J, Lakshmanan Y, Pound CR et al. Nuclear shape and nuclear matrix protein composition in prostate and seminal vesicles. Urology 1999; 54: 934-939.
24. Pannek J, Partin AW. Untersuchungen zur unterschiedlichen Karzinominzidenz von Prostata und Samenblasen. Akt Urol 2002; 33: 206-212.